Peter Adamietz
- Co-authors
- Helmuth HilzN. M. MeenenChristiane GoepfertRalf PörtnerAnny RudolphKlaus WielckensU. WiegersReinhard Bredehorst
- Topics
- PARP inhibition in cancer therapy (20 papers)Toxin Mechanisms and Immunotoxins (10 papers)Osteoarthritis Treatment and Mechanisms (7 papers)
- Cited by
- PhysiologyOncologyBiomaterials
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- GermanyUnited States
In The Last Decade
Peter Adamietz
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 691
- Oncology 541
- Biomedical Engineering 242
- Surgery 219
- Immunology 211
Countries citing papers authored by Peter Adamietz
This map shows the geographic impact of Peter Adamietz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Adamietz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Adamietz more than expected).
Fields of papers citing papers by Peter Adamietz
This network shows the impact of papers produced by Peter Adamietz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Adamietz. The network helps show where Peter Adamietz may publish in the future.
Co-authorship network of co-authors of Peter Adamietz
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Adamietz. A scholar is included among the top collaborators of Peter Adamietz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Adamietz. Peter Adamietz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 46 | |
| 3 | 25 | |
| 4 | 12 | |
| 5 | 194 | |
| 6 | 28 | |
| 7 | 111 | |
| 8 | [Treatment of cartilage defects]. | 5 |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 54 | |
| 12 | 16 | |
| 13 | 3 | |
| 14 | 63 | |
| 15 | 15 | |
| 16 | 31 | |
| 17 | 41 | |
| 18 | 13 | |
| 19 | 8 | |
| 20 | Proceedings: Is poly(ADP-ribose) covalently bound to nuclear proteins? | 3 |
About Peter Adamietz
Peter Adamietz is a scholar working on Physiology, Urology and Oncology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (20 papers), Toxin Mechanisms and Immunotoxins (10 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). The work is most often cited by research in Physiology (167 citations), Oncology (541 citations) and Biomaterials (191 citations). Peter Adamietz has collaborated with scholars based in Germany and United States. Frequent co-authors include Helmuth Hilz, N. M. Meenen, Christiane Goepfert, Ralf Pörtner, Anny Rudolph, Klaus Wielckens, U. Wiegers, Reinhard Bredehorst, Werner Fanick and R Bredehorst. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.